LDHC and lung carcinoma: As summarized by Jing W and colleagues, overexpression of LDHC in renal cell and lung cancer cell lines and a lung cancer xenograft mouse model greatly enhances cellular motility through regulation of epithelial-to-mesenchymal transition (EMT) and expression of matrix metalloproteinases (3, 4).